Successful treatment of atopic dermatitis refractory to dupilumab with baricitinib.
Dermatol Ther
; 35(11): e15802, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-36043599
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Azetidines
/
Dermatitis, Atopic
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Dermatol Ther
Journal subject:
DERMATOLOGIA
Year:
2022
Document type:
Article
Country of publication:
United States